Sibel Kabukçu Hacıoğlu

3PUBLICATIONS
20CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 28, 2026
Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study.

Sema Seçilmiş, Sibel Kabukçu Hacıoğlu, Fehmi Hindilerden

|May 06, 2021
Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?

Gülsüm Akgün Çağlıyan, Sibel Hacıoğlu, Başak Ünver Koluman

Pageof 1